Search Results - "Haber, Paul"

Alcohol use disorders by Connor, Jason P, PhD, Haber, Paul S, Prof, Hall, Wayne D, Prof

“…Summary Alcohol use disorders are common in developed countries, where alcohol is cheap, readily available, and heavily promoted. Common, mild disorders often…”
Get full text

Alcoholic Liver Disease in Asia, Europe, and North America by Liangpunsakul, Suthat, Haber, Paul, McCaughan, Geoff

“…Alcoholic liver diseases comprise a spectrum of clinical disorders and changes in liver tissue that can be detected by pathology analysis. These range from…”
Get full text

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition by Arkell, Thomas R., Lintzeris, Nicholas, Kevin, Richard C., Ramaekers, Johannes G., Vandrey, Ryan, Irwin, Christopher, Haber, Paul S., McGregor, Iain S.

“…Background The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a…”
Get full text

Alcohol use disorder and the gut by Haber, Paul S., Kortt, Nicholas C.

“…Acute and chronic gastrointestinal problems are common in the setting of excessive alcohol use, and excessive alcohol use is associated with injury to all…”
Get full text

An overview of the patterns of prescription opioid use, costs and related harms in Australia by Blanch, Bianca, Pearson, Sallie‐Anne, Haber, Paul S.

“…Aims To report Australian population trends in subsidized prescribed opioid use, total costs to the Australian government to subsidize these medicines and…”
Get full text

Hepatitis C treatment hesitancy among people with heroin dependence in Australia. A prospective cohort study by Tremonti, Chris, Teesson, Maree, Marel, Christina, Mills, Katherine, Haber, Paul S

Get full text

Blood transfusion is a rare but potential source of false-positive phosphatidylethanol by Nash, Emily, Fitzpatrick, Michael, Liu, Ken, Volovets, Anastasia, Sullivan, David, Khoo, Liane, Haber, Paul S

Get full text

Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial by Morley, Kirsten C., Baillie, Andrew, Fraser, Isabel, Furneaux-Bate, Ainsley, Dore, Glenys, Roberts, Michael, Abdalla, Ahmed, Phung, Nghi, Haber, Paul S.

“…There are no available medications for the management of alcohol dependence for patients with alcoholic liver disease (ALD).AimsTo conduct a multisite, double…”
Get full text

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic by Dunlop, Adrian, Lokuge, Buddhima, Masters, Debbie, Sequeira, Marcia, Saul, Peter, Dunlop, Grace, Ryan, John, Hall, Michelle, Ezard, Nadine, Haber, Paul, Lintzeris, Nicholas, Maher, Lisa

“…The impact of COVID-19 across health services, including treatment services for people who use drugs, is emerging but likely to have a high impact. Treatment…”
Get full text

Pharmacotherapeutic agents in the treatment of methamphetamine dependence by Morley, Kirsten C, Cornish, Jennifer L, Faingold, Alon, Wood, Katie, Haber, Paul S

“…Methamphetamine use is a serious public health concern in many countries and is second to cannabis as the most widely abused illicit drug in the world…”
Get more information

The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS) by Wilson, Jack, Mills, Katherine L, Sunderland, Matthew, Freeman, Tom P, Teesson, Maree, Haber, Paul S, Marel, Christina

“…Cannabis use is common among individuals with opioid use disorder, but it remains unclear whether cannabis use is associated with an increase or a reduction in…”
Get full text

N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial by Morley, Kirsten C, Peruch, Siena, Adams, Claire, Towers, Ellen, Tremonti, Chris, Watt, Joshua, Jamshidi1, Nazila, Haber, Paul S

“…Abstract N-acetyl cysteine (NAC) is a potent antioxidant that modulates glutamatergic signalling which is thought to play a role in alcohol use disorder (AUD)…”
Get full text

Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review) by Nguyen, Van Long, Haber, Paul S., Seth, Devanshi

“…Phosphatidylethanol (PEth) is a direct nonoxidative metabolite of ethanol that may be measured in clinical samples as a marker for monitoring alcohol…”
Get full text

Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse by Lawson, Samuel, Bryant, Jamie, Freund, Megan, Dizon, Joshua, Haber, Paul S., Shakeshaft, Anthony, Jefferies, Meryem, Farrell, Michael

“…Introduction The aim of this paper was to examine the client and psychosocial characteristics associated with polydrug use in patients with alcohol misuse as…”
Get full text

Vitamin B12 supplementation futile for preventing demyelination in ongoing nitrous oxide misuse by Blair, Christopher, Tremonti, Chris, Edwards, Leon, Haber, Paul S, Halmagyi, G Michael

Get full text

Hypothalamic-pituitary-adrenocortical response in alcohol-dependent patients during baclofen treatment and association with clinical outcome: Preliminary results by Logge, Warren, Hurzeler, Tristan, Arunogiri, Shalini, Towers, Ellen, Baillie, Andrew, Haber, Paul S., Morley, Kirsten

“…Baclofen has been shown to reduce alcohol consumption in some individuals with alcohol use disorder. This preliminary study aimed to evaluate i) the effect of…”
Get full text

Treatment of alcohol problems: current status and future directions by Haber, Paul S, Riordan, Benjamin C, Morley, Kirsten C

Get full text

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study by Addolorato, Giovanni, Dr, Leggio, Lorenzo, MD, Ferrulli, Anna, MD, Cardone, Silvia, MD, Vonghia, Luisa, MD, Mirijello, Antonio, MD, Abenavoli, Ludovico, MD, D'Angelo, Cristina, MD, Caputo, Fabio, MD, Zambon, Antonella, PhD, Haber, Paul S, Prof, Gasbarrini, Giovanni, Prof

“…Summary Background Intervention to achieve alcohol abstinence represents the most effective treatment for alcohol-dependent patients with liver cirrhosis;…”
Get full text

Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment by Haber, Paul S., Elsayed, Mahmoud, Espinoza, David, Lintzeris, Nicholas, Veillard, Anne-Sophie, Hallinan, Richard

“…•Opioid substitution treatment (OST) is often long-term.•Therefore opioid-related symptoms are of interest.•Few have reported opioid-related symptoms by…”
Get full text

Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial by Morley, Kirsten C, Kranzler, Henry R, Luquin, Natasha, Jamshidi, Nazila, Adams, Claire, Montebello, Mark, Tremonti, Chris, Dali, Gezelle, Logge, Warren, Baillie, Andrew, Teesson, Maree, Trent, Ronald, Haber, Paul S

“…There have been no well-controlled and well-powered comparative trials of topiramate with other pharmacotherapies for alcohol use disorder (AUD), such as…”
Get full text